Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

Click for more information

3.57%

14.5¢ resapp health limited

Ann: ResApp Provides SMARTCOUGH-C-2 Study Update, page-35

First 35 Last

Share
Profile

Follow
AlCp

2,044 Posts.

42

09/03/18

17:56

Post #: 31652631
Share

Originally posted by dougfr ↑

Great to see a steady rise in the sp from mid 6's not that long ago to around 14c, and holding, currently. Announcements, such as today's, only serve to underpin the growing confidence in the market place.

I am along term holder and have been steadily accruing since the crash and now hold significantly more stock than I did then with my average buy in price not far above the current sp. The thing that keeps me awake at night is the uncertainty of conducting paediatric trials in busy and stressful emergency departments involving tearful toddlers and frantic parents. Does anyone know why we did not opt to conduct the adult trials first and then run with the paediatric trials? Does it have something to do with Bill Gates' initial funding of the research?

Expand

It was first developed for paediatric so they've gathered more data and done more testing, then it was extend to Adult only a 12-18 months (likely just to see if it could) and that also showed very good diagnosis accuracy.

RAP Price at posting: 14.0¢ Sentiment: Buy Disclosure: Held
2 Upvote

1 Great analysis

Reply

First 35 Last

Add RAP (ASX) to my watchlist